A randomized, double blind, 12 week, parallel group, placebo controlled study of the efficacy and safety of RO4917523 in patients

An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for

A series of lectures, inspired by Sir Arthur Conan Doyle, will highlight the University of Edinburgh’s internationally acclaimed medical research

My name is Luke Papini, I am 20 years old and on the 18th of April 2012, I was diagnosed

On May 7, 2012 Conor Lavery and his co-workers are taking part in the team event at the Belfast City

Download the February newsletter below. PWC Update February 2012 (PDF, 245 KB)

Download the December newsletter below. PWC Newsletter December 2011 (PDF, 662 KB)

Dame Stephanie “Steve” Shirley, a pioneering figure of the IT industry now turned philanthropist, has pledged £1 million to the

The Helen Maude Garfit fund has raised a fantastic £54,000 for the Patrick Wild Centre. Merken

On Thursday 20th October 2011, at 6pm, Prof. Peter Kind, co-Director of the Patrick Wild Centre, will give a talk

UK regulatory approvals are now in place for the trials of the Novartis compound, AFQ056, for individuals with Fragile X

The Helen Maude Garfit fund has been recently established at the University of Edinburgh to support research into Fragile X